Christina Shafer Power of Attorney Filing for Neurogene Inc.

This SEC Form 3 filing documents a power of attorney granted by Christina Shafer, Chief Commercial Officer of Neurogene Inc. (NGNE), to several individuals including Rachel McMinn, Christine Mikail, Donna M. Cochener, Ryan A. Murr, and Branden C. Berns. The power of attorney authorizes these individuals to prepare and submit SEC filings on Shafer's behalf, including Form ID, Forms 3, 4, and 5 related to Section 16 reporting requirements. The authorization is specifically for filings related to Shafer's holdings and transactions in Neurogene securities. The power of attorney remains in effect until Shafer is no longer required to file Section 16 forms with the SEC or until revoked in writing. The filing was executed on April 20, 2026, and signed by Donna M. Cochener as attorney-in-fact for Christina Shafer.